2980758-31-2
Chemical Structure
STAT3-IN-12
- CAS No.: 2980758-31-2
- Formula:C28H30N4O2
- Molecular Weight:454.56
IUPAC Name: 2,6-bis(3-methoxyphenyl)-1,7-dipropyl-1,7-dihydrobenzo[1,2-d:4,5-d']diimidazole
InChIKey: BWCIDDGTJILXKX-UHFFFAOYSA-N
SMILES: CCCN1C2=C(C=C3C(N(CCC)C(C4=CC=CC(OC)=C4)=N3)=C2)N=C1C5=CC=CC(OC)=C5
Biological Activity: STAT3-IN-12 is a potent STAT3 signal inhibitor that can inhibit IL-6 induced JAK/STAT3 signalling pathway activation. STAT3-IN-12 inhibits cancer cell growth, migration, and induce cell apoptosis as well as cycle arrest. STAT3-IN-12 can be used in cancer-related research, such as hepatocellular carcinoma (HCC) and oesophageal carcinoma[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
STAT3-IN-12 | 99.87% | STAT3-IN-12 is a potent STAT3 signal inhibitor that can inhibit IL-6 induced JAK/STAT3 signalling pathway activation. STAT3-IN-12 inhibits cancer cell growth, migration, and induce cell apoptosis as well as cycle arrest. STAT3-IN-12 can be used in cancer-related research, such as hepatocellular carcinoma (HCC) and oesophageal carcinoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
